Cyclosporine: A new adjuvant therapy for giant cell arteritis?
β Scribed by D. Wendling; B. Hory; D. Blanc
- Publisher
- John Wiley and Sons
- Year
- 1985
- Tongue
- English
- Weight
- 251 KB
- Volume
- 28
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Background. Treatment of multisystem Langerhans cell histiocytosis (LCH) remains difficult. Various regimens of single and multiagent chemotherapy have been used, but a significant proportion of patients fail to respond to treatment. Procedure. We have evaluated the use of cyclosporine A (CSA) in a
consequences of a variety of compounds that are used may be quite significant (1-5). As noted by Pollard and Hultman, these products are available and used worldwide, but the extent to which they are currently used, or have previously been used, by different groups (in the US and in other countries)
## Abstract ## Objective Glucocorticoid (GC) therapy for giant cell arteritis (GCA) is effective but requires prolonged administration, resulting in adverse side effects. The goal of the current study was to test the hypothesis that induction treatment with highβdose pulse intravenous (IV) methylp